CLEVELAND, Nov. 28, 2018 /PRNewswire/ -- GenomOncology LLC, a leading provider of end-to-end precision medicine solutions in oncology, has developed a solution to integrate IHC, FISH, NGS and Karyotyping in order to provide therapy and clinical trial recommendations. This innovative work...
from PR Newswire: https://ift.tt/2RltrvN
No comments:
Post a Comment